Drug Trial Radar · NCT06552416
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Jun 16, 2025
Primary completion
Sep 2029
Study completion Sep 2029
Sponsor
- Lead sponsor
- Marker Therapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- University of Kansas Medical Center; H. Lee Moffitt Cancer Center and Research Institute; City of Hope National Medical Center; FDA Office of Orphan Products Development
- First posted
- Aug 14, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a Phase 1 multicenter, open-label study evaluating the safety and efficacy of escalating doses of MT-401-OTS in 2 participant populations: 1) Those with intermediate or high-risk AML per 2022 ELN criteria who have evidence of MRD and/or \</= 10% blast following prior induction therapy or at least 4 cycles of nonintensive therapy and 2) those with high- or very-high-risk MDS per 2023 IWG criteria and who have residual disease with \</= 10% blasts following treatment with an HMA-based therapy.
Conditions
- Acute Myeloid Leukemia, in Relapse
- MDS
Interventions
MT-401-OTSDrug
MT-401-OTS is an off the shelf cellular therapy product given by IV infusion through either a peripheral or central line.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of MT-401-OTSTime frame: Through study completion. Approximately 5 years
- Tolerability of MT-401-OTSTime frame: Through study completion. Approximately 5 years
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center)
Duarte, California · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
KU Cancer Center
Kansas City, Kansas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.